ASHP Policy Position 0720
STANDARDIZING PREFIXES AND SUFFIXES IN DRUG PRODUCT NAMES
Status: Current
To collaborate with others, including the United States Pharmacopeia and the Food and Drug Administration, in standardizing and defining the meaning of prefixes and suffixes for prescription and nonprescription drugs to prevent medication errors and ensure patient safety.
This policy was reviewed in 2022 by the Council on Public Policy and was found to still be appropriate.
Rationale
This policy position was developed before preparation of a policy rationale became routine, so no rationale is available.